Peripherally Restricted Cannabinoids for the Treatment of Pain

E-ISSN： 1875-9114|35|10|917-925

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.10, 2015-10, pp. : 917-925

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Cannabinoids in Chronic Pain Patients Remains Hazy

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. : 972-972

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression

By Michalovicz Lindsay Konat Gregory

Metabolic Brain Disease, Vol. 29, Iss. 1, 2014-03 ,pp. : 75-86

Springer Publishing Company

Access to resources Recommend Favorite

AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 9, 2015-05 ,pp. : 2406-2418

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cannabinoids: Novel Medicines for the Treatment of Huntington's Disease

Recent Patents on CNS Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 41-48

Bentham Science Publishers

Access to resources Recommend Favorite

High‐quality evidence lacking for cannabinoids in medical treatment

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 10, 2015-10 ,pp. : 1-5

John Wiley & Sons Inc

Access to resources Recommend Favorite